Too much overwhelms protective mechanisms
Aquat Toxicol 9:91103 Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, Serrano JA, Tietge JE, Villeneuve DL (2010) Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment
BPC-157 + GHK-Cu Stack: Evidence, Mechanism Overlap, and Protocol At a glance BPC-157 structure / 15-amino-acid sequence derived from gastric juice protein BPC GHK-Cu structure / tripeptide glycine-histidine-lysine bound to copper (Cu2+) Primary BPC-157 targets / VEGFR2, FAK/paxillin, nitric-oxide pathway Primary GHK-Cu targets / TGF-beta1, collagen I/III genes, MMP-2/9 regulation Mechanism overlap / extracellular matrix remodeling, angiogenesis, anti-inflammatory cytokine reduction Human RCT data for the combination / none as of mid-2025 Typical BPC-157 dose range / 200-500 mcg per day subcutaneous or intramuscular Typical GHK-Cu dose range / 1-2 mg per day subcutaneous
Cysteine and L-Methionine - Amino acids known to thicken hair